VET3-TGI, An Oncolytic Vaccinia Targeting TGF-Beta

Time: 5:15 pm
day: Day One


  • TGF-beta inhibition is a potentially powerful approach to cancer therapy
  • Oncolytic viral expression of a TGF-beta inhibitor overcomes many of the limitations of existing therapies
  • Development of a multi-mechanistic oncolytic virus incorporating a TGF-beta inhibitor results in a potent pre-clinical cancer therapy